A comprehensive analysis of the prognostic value, expression characteristics and immune correlation of MKI67 in cancers
Our comprehensive analysis may supply useful guidance on MKI67 applicability across various cancer types. These observed results contribute to the promise of MKI67 in a realistic clinical setting and improve the outcomes of cancer patients.
Authors
- Xiaolan Pan (ORCID: https://orcid.org/0000-0001-5200-6517)
- Jingyu Su (ORCID: https://orcid.org/0009-0002-2108-9713)
- Jie Zhao (ORCID: https://orcid.org/0000-0001-5403-9865)
- Min Fang (ORCID: https://orcid.org/0009-0008-7336-9606)
- Caibiao Wei (ORCID: https://orcid.org/0009-0007-5564-7695)
- Yuling Qin (ORCID: https://orcid.org/0000-0001-7035-4072)
- Qiumei Lin (ORCID: https://orcid.org/0000-0003-2845-3004)
- Jie Gao (ORCID: https://orcid.org/0000-0002-6932-8675)
- Fengfei Liu
- Huiliu Zhao
Institutions
- Guangxi Medical University (CN)
- Guangxi Maternal and Child Health Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.3389/fimmu.2025.1531708
- Citations
- 5
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 5.23